Inhibition of gastric acid secretion in the rat by orally‐administered synthetic prostaglandin analogues: enantiomorphs of 15‐hydroxy‐15‐methyl‐9‐oxoprostanoic acid

W. Lippmann
DOI: https://doi.org/10.1111/j.2042-7158.1974.tb09185.x
1974-10-01
Abstract:As with certain natural prostaglandins, synthetic prostaglandin analogues, e.g. 1 1-deoxyprostaglandins, may inhibit gastric acid secretion. Various of these synthetic PGE-type analogues inhibit basal and pentagastrin-induced gastric acid secretion in the rat when given subcutaneously (Lippmann, 1969, 1970, 1971), and 15-hydroxy15-methyl-9-oxoprostanoic acid (AY-22469) inhibits secretion when administered orally (Lippmann, 1973). In the present study the effects of orally-administered enantiomorphs of AY-22469 have been determined on basal gastric acid secretion and also on the incidence of diarrhoea. Natural prostaglandins increase the incidence of diarrhoea thus limiting their potential usefulness (Horton, Main & others, 1968; Misiewicz, Waller & others, 1969). Basal gastric acid secretory activity was measured according to the method of Shay, Sun & Gruenstein (1954) as described by Lippmann (1973) in female albino rats. Appearance of diarrhoea was noted in groups of 8-10 rats (24 h-starved) or mice (nonstarved) 60 min after the oral administration of the analogue. The percent of animals exhibiting diarrhoea was determined; the data were evaluated by probit analysis (Finney, 1947).
What problem does this paper attempt to address?